Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.
Revenue of Biocon Limited (BIOCON.NS)
Revenue in 2023 (TTM): $1.75 B
According to Biocon Limited's latest financial reports the company's current revenue (TTM) is $1.75 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Biocon Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.75 B | $1.09 B | $491.99 M | $190.68 M | $121.14 M |
| 2022 | $1.32 B | $889.9 M | $307.59 M | $106.29 M | $54.82 M |
| 2021 | $950.76 M | $628.07 M | $245.46 M | $116.48 M | $76.82 M |
| 2020 | $825.8 M | $563.94 M | $227.47 M | $127.65 M | $87.73 M |
| 2019 | $735.92 M | $492.54 M | $217.05 M | $140.51 M | $88.64 M |
| 2018 | $637.54 M | $412.56 M | $205.24 M | $143.94 M | $107.26 M |
| 2017 | $471.32 M | $277.21 M | $123.16 M | $72.27 M | $44.12 M |
| 2016 | $455.64 M | $284.01 M | $116.32 M | $100.67 M | $72.52 M |
| 2015 | $403.42 M | $245.54 M | $119.38 M | $145.42 M | $106.17 M |
| 2014 | $362.45 M | $213.35 M | $101.18 M | $73.94 M | $58.93 M |
| 2013 | $337.82 M | $196.99 M | $88.03 M | $63.71 M | $49.03 M |
| 2012 | $287.46 M | $163.52 M | $94.5 M | $72.3 M | $60.29 M |
| 2011 | $242.76 M | $141.68 M | $67.94 M | $46.5 M | $40.09 M |
| 2010 | $272.56 M | $13.8 M | $74.39 M | $52.98 M | $43.54 M |
| 2009 | $241.26 M | $102.48 M | $60.25 M | $41.64 M | $34.74 M |
| 2008 | $162.53 M | $63.2 M | $45.96 M | $30.8 M | $11.03 M |
| 2007 | $98.74 M | $43.67 M | $39.51 M | $27.36 M | $54.96 M |
| 2006 | $97.48 M | $44.07 M | $27.79 M | $25 M | $23.73 M |
| 2005 | $81.45 M | $34.04 M | $27.54 M | $24 M | $20.61 M |
| 2004 | $76.58 M | $34.2 M | $28.39 M | $25.49 M | $23.4 M |
| 2003 | $59.46 M | $28.21 M | $21.53 M | $19.15 M | $16.43 M |